NLRP3 and lung carcinoma: Moreover, in lung cancer, previous studies have shown that NLRP3 can enhance the proliferation of A549 cells through IL-1β/ERK/CREB and IL-18/AKT/CREK signaling pathways, and promote tumor metastasis by reducing E-cadherin and increasing Snail expression [31].